All Stories

  1. Complement factor D targeting protects endotheliopathy in organoid and monkey models of COVID-19

    Article • Cell Stem Cell, October 2023, Elsevier

    Dr. Chiharu Moriya, Yasunori Nio

  2. Phosphodiesterase 4 inhibitors in diabetic nephropathy

    Article • Cellular Signalling, February 2022, Elsevier

    Yasunori Nio

  3. Ameliorative effect of anti-complement factor antibody on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected macaque

    Article • Translational and Regulatory Sciences, January 2021, AMED iD3 Catalyst Unit

    Yasunori Nio

  4. The promise of human organoids in the digestive system

    Article • Cell Death and Differentiation, November 2020, Springer Science + Business Media

    Yasunori Nio

  5. Ameliorative effect of phosphodiesterase 4 and 5 inhibitors in deoxycorticosterone acetate‐salt hypertensive uni‐nephrectomized KKA y mice

    Article • The FASEB Journal, September 2020, Wiley

    Yasunori Nio

  6. Polygenic architecture informs potential vulnerability to drug-induced liver injury

    Article • Nature Reports Stem Cells, September 2020, Springer Science + Business Media

    Yasunori Nio

  7. Identification of inhibitors of dengue viral replication using replicon cells expressing secretory luciferase

    Article • Antiviral Research, December 2019, Elsevier

    Yasunori Nio

  8. Bardoxolone methyl as a novel potent antiviral agent against hepatitis B and C viruses in human hepatocyte cell culture systems.

    Article • Antiviral Research, September 2019, Elsevier

    Yasunori Nio

  9. Stearoyl-CoA desaturase-1 is required for flavivirus RNA replication

    Article • Antiviral Research, May 2019, Elsevier

    Yasunori Nio

  10. Improvement of pulmonary arterial hypertension, inflammatory response, and epithelium injury by dual activation of cAMP/cGMP pathway in a rat model of monocrotaline-induced pulmonary hypertension

    Article • Bioscience Biotechnology and Biochemistry, March 2019, Taylor & Francis

    Yasunori Nio

  11. Organoid Models of Development and Disease Towards Therapy

    Article • January 2019, Springer Science + Business Media

    Yasunori Nio

  12. Inhibitory effect of fasiglifam on hepatitis B virus infections through suppression of the sodium taurocholate cotransporting polypeptide

    Article • Biochemical and Biophysical Research Communications, June 2018, Elsevier

    Yasunori Nio

  13. Bombesin receptor subtype-3-expressing neurons regulate energy homeostasis through a novel neuronal pathway in the hypothalamus

    Article • Brain and Behavior, December 2017, Wiley

    Yasunori Nio

  14. Phosphodiesterase 4 inhibitor and phosphodiesterase 5 inhibitor combination therapy has antifibrotic and anti-inflammatory effects in mdx mice with Duchenne muscular dystrophy

    Article • The FASEB Journal, December 2017, Federation of American Societies For Experimental Biology (FASEB)

    Yasunori Nio

  15. Podocan Is Expressed in Blood and Adipose Tissue and Correlates Negatively With the Induction of Diabetic Nephropathy

    Article • Journal of the Endocrine Society, May 2017, Endocrine Society

    Yasunori Nio

  16. A Selective Bombesin Receptor Subtype 3 Agonist Promotes Weight Loss in Male Diet-Induced–Obese Rats With Circadian Rhythm Change

    Article • Endocrinology, March 2017, Endocrine Society

    Yasunori Nio

  17. Liver-specific mono-unsaturated fatty acid synthase-1 inhibitor for anti-hepatitis C treatment

    Article • Antiviral Research, August 2016, Elsevier

    Yasunori Nio

  18. Fatty acid biosynthesis is involved in the production of hepatitis B virus particles

    Article • Biochemical and Biophysical Research Communications, June 2016, Elsevier

    Yasunori Nio

  19. Monocyte chemoattractant protein-1 (MCP-1) deficiency enhances alternatively activated M2 macrophages and ameliorates insulin resistance and fatty liver in lipoatrophic diabetic A-ZIP transgenic mice

    Article • Diabetologia, September 2012, Springer Science + Business Media

    Yasunori Nio

  20. Adiponectin suppresses tumorigenesis in ApcMin/+ mice

    Article • Cancer Letters, February 2010, Elsevier

    Yasunori Nio

  21. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions

    Article • Nature Reports Stem Cells, February 2007, Springer Science + Business Media

    Yasunori Nio

  22. Subgenomic replicon derived from a cell line infected with the hepatitis C virus

    Article • Biochemical and Biophysical Research Communications, May 2002, Elsevier

    Yasunori Nio